Flaharty Asset Management, LLC Bristol Myers Squibb CO Transaction History
Flaharty Asset Management, LLC
- $485 Million
- Q2 2025
A detailed history of Flaharty Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Flaharty Asset Management, LLC holds 740 shares of BMY stock, worth $34,091. This represents 0.01% of its overall portfolio holdings.
Number of Shares
740
Previous 731
1.23%
Holding current value
$34,091
Previous $44,000
22.73%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.5MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.98 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.31 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.98 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...